Literature DB >> 20066567

Lack of correlation between a self-administered subjective GERD questionnaire and pathologic GERD diagnosed by 24-h esophageal pH monitoring.

Kevin Chan1, Geoffrey Liu, Linda Miller, Clement Ma, Wei Xu, Christopher M Schlachta, Gail Darling.   

Abstract

INTRODUCTION: Self-reported reflux symptoms do not always correspond to pathologic gastroesophageal reflux disease (GERD). We evaluated whether GERD-related symptoms in the self-reported Mayo-GERD questionnaire (GERDQ) were correlated with current gold standard definitions of pathologic GERD.
METHODS: Three hundred thirty-six consecutive consenting individuals with GERD symptoms referred for 24-h esophageal pH monitoring completed a baseline GERDQ. Univariate and multivariate analyses identified questions that were most associated with percent total time pH<4 at distal probe (DT) >4% or DeMeester score (DS) >or=14.7, two accepted definitions of pathologic GERD. A risk score was created from these analyses, followed by generation of receiver operating characteristic curves and determination of C-statistics, sensitivity, and specificities at various cut points, with prespecified minimal values of each that would be required to meet the definition of "potential clinical utility."
RESULTS: Forty-nine percent of patients were found to have pathologic GERD; half the patients (not necessarily those with pathologic GERD) described suffering from severe or very severe heartburn or acid regurgitation in the past year. Univariate logistic regression analysis identified six of 22 key GERD questions that were significantly related to DT or DS, in addition to age and gender. Three questions (duration of symptoms, nocturnal heartburn, hiatal hernia) along with age and gender remained significant in multivariate analyses. A risk score (RS) was created from these five questions separately for DT and DS. For DT, the C-statistic for RS was 0.75, and at the optimal cut point of >or=6 that maximizes sensitivity (SS) and specificity (SP), SS was 68% and SP was 72%. For DS, the C-statistic was 0.73, and at the optimal cut point, SS was 82%and SP 60%. When considering other cut points, the rare extreme case of very low RS (<or=2) was strongly predictive of lack of pathologic GERD: for DT, SS 100%/SP 18%, negative predictive value (NPV) 100%; and for DS, SS 97%, SP 25%, NPV 88%. However, only 10-15% of patients referred for pH testing had RS scores of <or=2.
CONCLUSION: Self-reported prolonged history of GERD-like symptoms, nocturnal heartburn, history of a hiatus hernia, and male gender were associated with abnormal 24-h esophageal pH monitoring. However, these factors lack clinical utility to predict pathologic GERD in patients referred for pH testing. We found that 51% of patients with severe GERD symptoms do not have true pathological GERD on objective testing. The clinical implications of this study are significant in that treatment with acid-suppressing medication in such patients would be inappropriate.

Entities:  

Mesh:

Year:  2010        PMID: 20066567     DOI: 10.1007/s11605-009-1137-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

Review 1.  Gastro-oesophageal reflux disease.

Authors:  Paul Moayyedi; Nicholas J Talley
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

2.  Impact of gastroesophageal reflux on survival in the community.

Authors:  Nicholas J Talley; G Richard Locke; M McNally; Cathy D Schleck; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2007-09-26       Impact factor: 10.864

3.  Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant.

Authors:  E Colas-Atger; B Bonaz; E Papillon; N Gueddah; A Rolachon; R Bost; J Fournet
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

4.  Diagnosis of gastroesophageal reflux disease using a new questionnaire.

Authors:  Yasuyuki Shimoyama; Motoyasu Kusano; Sayaka Sugimoto; Osamu Kawamura; Masaki Maeda; Keiko Minashi; Shikou Kuribayashi; Tatsuya Higuchi; Hiroaki Zai; Kyoko Ino; Tsutomu Horikoshi; Fumitaka Moki; Tadashi Sugiyama; Munetoshi Toki; Tsuneo Ohwada; Masatomo Mori
Journal:  J Gastroenterol Hepatol       Date:  2005-04       Impact factor: 4.029

5.  A new questionnaire for gastroesophageal reflux disease.

Authors:  G R Locke; N J Talley; A L Weaver; A R Zinsmeister
Journal:  Mayo Clin Proc       Date:  1994-06       Impact factor: 7.616

6.  Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

Authors:  E Dimenäs; G Carlsson; H Glise; B Israelsson; I Wiklund
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 7.  Diagnostic utility of reflux disease symptoms.

Authors:  M Shaw
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

8.  Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?

Authors:  E Dimenäs; H Glise; B Hallerbäck; H Hernqvist; J Svedlund; I Wiklund
Journal:  Scand J Gastroenterol       Date:  1993-08       Impact factor: 2.423

9.  Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease.

Authors:  K H Fuchs; T R DeMeester; M Albertucci
Journal:  Surgery       Date:  1987-10       Impact factor: 3.982

10.  Influence of age and gender on gastroesophageal reflux in symptomatic patients.

Authors:  R B Ter; B T Johnston; D O Castell
Journal:  Dis Esophagus       Date:  1998-04       Impact factor: 3.429

View more
  11 in total

1.  The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease.

Authors:  Nisa Netinatsunton; Siriboon Attasaranya; Bancha Ovartlarnporn; Sulee Sangnil; Sopa Boonviriya; Teerha Piratvisuth
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

2.  Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications.

Authors:  David A Kleiman; Matthew J Sporn; Toni Beninato; Yasmin Metz; Carl Crawford; Thomas J Fahey; Rasa Zarnegar
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

Review 3.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

4.  Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force.

Authors:  Shobna J Bhatia; D Nageshwar Reddy; Uday C Ghoshal; V Jayanthi; Philip Abraham; Gourdas Choudhuri; S L Broor; Vineet Ahuja; Philip Augustine; V Balakrishnan; D K Bhasin; Naresh Bhat; Ashok Chacko; Sunil Dadhich; G K Dhali; Pankaj S Dhawan; Manisha Dwivedi; Mahesh K Goenka; Abraham Koshy; Ajay Kumar; Sri Prakash Misra; Shrikant Mukewar; E PedaVeer Raju; K T Shenoy; S P Singh; Ajit Sood; R Srinivasan
Journal:  Indian J Gastroenterol       Date:  2011-07-27

5.  ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.

Authors:  C Prakash Gyawali; Dustin A Carlson; Joan W Chen; Amit Patel; Robert J Wong; Rena H Yadlapati
Journal:  Am J Gastroenterol       Date:  2020-09       Impact factor: 12.045

6.  Gastroesophageal reflux disease and antireflux surgery-what is the proper preoperative work-up?

Authors:  Brian Bello; Marco Zoccali; Roberto Gullo; Marco E Allaix; Fernando A Herbella; Arunas Gasparaitis; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

7.  Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease.

Authors:  David A Kleiman; Toni Beninato; Brian P Bosworth; Laurent Brunaud; Thomas Ciecierega; Carl V Crawford; Brian G Turner; Thomas J Fahey; Rasa Zarnegar
Journal:  J Gastrointest Surg       Date:  2013-11-09       Impact factor: 3.452

8.  Unsedated transnasal endoscopy with ultrathin endoscope as a screening tool for research studies.

Authors:  Robert M Siwiec; Kulwinder Dua; Sri Naveen Surapaneni; Mohammed Hafeezullah; Benson Massey; Reza Shaker
Journal:  Laryngoscope       Date:  2012-05-07       Impact factor: 3.325

Review 9.  The effect of bariatric surgery on gastroesophageal reflux disease.

Authors:  Mustafa El-Hadi; Daniel W Birch; Richdeep S Gill; Shahzeer Karmali
Journal:  Can J Surg       Date:  2014-04       Impact factor: 2.089

10.  Self-reported sleep bruxism and nocturnal gastroesophageal reflux disease in patients with obstructive sleep apnea: relationship to gender and ethnicity.

Authors:  Sean Hesselbacher; Shyam Subramanian; Shweta Rao; Lata Casturi; Salim Surani
Journal:  Open Respir Med J       Date:  2014-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.